戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tively, with concomitant amelioration of rat adjuvant-induced arthritis.
2 nic inflammatory process associated with rat adjuvant-induced arthritis.
3 destly decreased the rat paw swelling in rat adjuvant-induced arthritis.
4 oliferation and a remarkable protection from adjuvant-induced arthritis.
5                    In this study, on the rat adjuvant-induced arthritis (AA) model of human rheumatoi
6 les were assessed and compared in vivo in an adjuvant-induced arthritis (AA) rat model in order to id
7 ncentrations in spleens from Lewis rats with adjuvant-induced arthritis (AA), an animal model of rheu
8 H37Ra leads to development of polyarthritis (adjuvant-induced arthritis; AA) that shares several feat
9                                              Adjuvant-induced arthritis (AIA) and collagen-induced ar
10                                              Adjuvant-induced arthritis (AIA) in rats is a widely use
11 estigate whether Met-RANTES could ameliorate adjuvant-induced arthritis (AIA) in the rat.
12                                              Adjuvant-induced arthritis (AIA) is one of many animal m
13 tudy was to address this issue using the rat adjuvant-induced arthritis (AIA) model of human RA.
14  treatment of ongoing disease, using the rat adjuvant-induced arthritis (AIA) model of human rheumato
15 osteoclast-mediated bone resorption in a rat adjuvant-induced arthritis (AIA) model, as well as human
16 uscular injection of naked DNA using the rat adjuvant-induced arthritis (AIA) model.
17        Clinical and histologic assessment of adjuvant-induced arthritis (AIA) was performed over a 42
18                                              Adjuvant-induced arthritis (AIA) was used as the model s
19                   In this study, we used rat adjuvant-induced arthritis (AIA), a model for RA, to def
20 gate the role of IL-4 in angiogenesis in rat adjuvant-induced arthritis (AIA), a model for rheumatoid
21  of CC chemokines and their receptors in rat adjuvant-induced arthritis (AIA), a model for rheumatoid
22             Preventatively, AxCAIL-4 reduced adjuvant-induced arthritis (AIA)- and/or AIA/adenoviral-
23  Hsp65 affords protection against subsequent adjuvant-induced arthritis (AIA).
24  in rat collagen-induced arthritis (CIA) and adjuvant-induced arthritis (AIA).
25 eutically was capable of ameliorating rat of adjuvant-induced arthritis (AIA).
26  weight were measured following induction of adjuvant-induced arthritis (AIA).
27 8-like protein during the development of rat adjuvant-induced arthritis (AIA).
28 induced in Lewis rats by adjuvant injection (adjuvant-induced arthritis [AIA] model) and scored for i
29 sess promising pharmacological properties in adjuvant-induced arthritis and edema analgesia models.
30 acrophages and suppresses the progression of adjuvant-induced arthritis and experimental allergic enc
31 ta injection in the rabbit) and chronic (rat adjuvant-induced arthritis and mouse collagen-induced ar
32 ing that Ltab-Ncr3 is specific in regulating adjuvant-induced arthritis but not antigen-induced autoi
33  paw edema, ED(50) = 5.4 mg/kg) and chronic (adjuvant induced arthritis, ED(50) = 0.25 mg/kg) models
34 luated in rat collagen-induced arthritis and adjuvant-induced arthritis, following oral treatment.
35 with subsequent evaluation in a rat model of adjuvant-induced arthritis (Freund's complete adjuvant).
36 ibitor, 21b, which significantly ameliorated adjuvant-induced arthritis in a rat model.
37            When tested in a chronic model of adjuvant-induced arthritis in rat, the ED50 of 5 (0.9 mg
38 midazoles showed excellent inhibition in the adjuvant induced arthritis model (e.g., ED50 = 0.02 mpk
39 e 21b was found to be very active in the rat adjuvant-induced arthritis model (ED50 = 0.05 mg/kg) and
40                                        In an adjuvant-induced arthritis model in rats, 37 prevented j
41                                Using the rat adjuvant-induced arthritis model of human RA, we demonst
42       We examined this proposition using the adjuvant-induced arthritis model of human rheumatoid art
43 f IL-13 in angiogenesis in vivo, using a rat adjuvant-induced arthritis model of RA.
44 omponent celastrol for this attribute in the adjuvant-induced arthritis model of RA.
45     Results from in vivo studies using a rat adjuvant-induced arthritis model showed specific inhibit
46 7, and CCR8 and showed excellent efficacy in adjuvant-induced arthritis model, collagen-induced arthr
47 hilia model and decreased paw edema in a rat adjuvant-induced arthritis model.
48  in measures of disease progression in a rat adjuvant-induced arthritis model.
49 maged in vivo with a gamma camera in the rat adjuvant-induced arthritis model.
50 t of inflammatory conditions associated with adjuvant-induced arthritis of the TMJ.
51                                       In the adjuvant-induced arthritis rat model, CHMFL-BTK-11 ameli
52                                           In adjuvant-induced arthritis rats treated with Cit-ME, dis
53 ssues, as well as in the serum and joints of adjuvant-induced arthritis rats.
54 Lewis rats with IL-21R.Fc after induction of adjuvant-induced arthritis resulted in reversal of disea
55                                           In adjuvant-induced arthritis, the therapeutic administrati
56 tal allergic encephalomyelitis, collagen and adjuvant-induced arthritis, uveitis, and diabetes in the
57                                              Adjuvant-induced arthritis was induced in Lewis rats.
58 y, male Lewis rats with mycobacteria-induced adjuvant-induced arthritis were treated with IL-1Ra or P